Patent · US Active

Tricyclic ASK1 inhibitors

US10919911B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 12, 2019
Grant dateFeb 16, 2021
Priority date
Expiry dateApr 12, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compounds, preferably ASK1 inhibitor compounds, compositions thereof, and methods of their preparation, and methods of inhibiting ASK1 and methods for treating disorders mediated by ASK1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.